Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod

Short resume:

blood
90%
betrixaban
80%
percent
70%
clots
60%

[Updated, 6/23/17, 6:23 pm, see below.] A Portola Pharmaceuticals drug developed to prevent risky and potentially fatal blood clots in patients who are hospitalized for an extended period of time received FDA approval on Friday.
Source Xconomy
Read More…

More News


Be the first to comment

Leave a Reply

Your email address will not be published.


*